secwatch.observer — SEC 8-K summary
======================================

Issuer:     BAXTER INTERNATIONAL INC (BAX)
CIK:        0000010456
Form:       8-K
Filed at:   2023-08-21T23:59:59+00:00
Accession:  0001628280-23-030139
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Baxter appoints former Quest CEO Stephen Rusckowski to board; director Mahoney resigns
--------------------------------------------------------------------------------

- Stephen H. Rusckowski appointed to Baxter board effective August 21, 2023; will serve on Compensation and Quality committees.
- Rusckowski is former CEO and Chairman of Quest Diagnostics (2012-2022) and former CEO of Philips Healthcare.
- Michael Mahoney to resign from board effective September 13, 2023; cites no disagreement with Baxter.
- Board size increases to 12 upon Rusckowski's appointment, then decreases to 11 after Mahoney's departure.
- Rusckowski receives standard non-employee director compensation and prorated equity award for 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/10456/000162828023030139/0001628280-23-030139-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/10456/000162828023030139/bax-20230818.htm
  HTML page:      https://secwatch.observer/filing/0001628280-23-030139

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer